Summary
Axon Enterprise, Inc. reported strong revenue growth in the second quarter of 2022, with total net sales reaching $285.6 million, a 30.5% increase year-over-year. This growth was primarily driven by the Software and Sensors segment, which saw a 41.2% surge, and robust performance in the TASER segment, up 20.5%. The company also achieved significant profitability, reporting net income of $51.0 million, a substantial turnaround from the net loss of $47.1 million in the prior year period. This improvement was largely due to a significant decrease in stock-based compensation expenses, coupled with strong revenue growth and effective cost management. Looking ahead, Axon revised its full-year 2022 revenue guidance upward to a range of $1.07 billion to $1.12 billion. The company continues to invest in its future, with projected capital expenditures of $80 million to $90 million. Despite increased costs in areas like freight and labor impacting gross margins, Axon's strategic focus on its growing software and services offerings, coupled with the strong demand for its TASER products, positions it well for continued expansion. Investors should note the significant unrealized gains from strategic investments which boosted net income this quarter, a factor that may not be recurring.
Financial Highlights
49 data points| Revenue | $285.61M |
| Cost of Revenue | $111.65M |
| Gross Profit | $173.96M |
| R&D Expenses | $57.55M |
| SG&A Expenses | $95.00M |
| Operating Expenses | $152.55M |
| Operating Income | $21.41M |
| Net Income | $50.96M |
| EPS (Basic) | $0.72 |
| EPS (Diluted) | $0.71 |
| Shares Outstanding (Basic) | 71.04M |
| Shares Outstanding (Diluted) | 72.28M |
Key Highlights
- 1Total net sales increased by 30.5% to $285.6 million for the three months ended June 30, 2022, compared to $218.8 million in the prior year period.
- 2Net income was $51.0 million for the three months ended June 30, 2022, a significant improvement from a net loss of $47.1 million in the same period of 2021.
- 3Software and Sensors segment revenue grew by 41.2% year-over-year, driven by strong performance in Axon Evidence and cloud services, and Axon Fleet.
- 4TASER segment revenue increased by 20.5%, primarily due to strong sales of the TASER 7 device and cartridges.
- 5Gross margin as a percentage of net sales decreased slightly to 60.9% from 63.0% year-over-year, impacted by higher freight and labor costs.
- 6Sales, General, and Administrative (SG&A) expenses decreased significantly by 46.5%, largely due to a substantial reduction in stock-based compensation expense.
- 7Full-year 2022 revenue guidance was revised upward to between $1.07 billion and $1.12 billion.